Literature DB >> 25020235

Critical care and vitamin D status assessment: what about immunoassays and calculated free 25OH-D?

Anne-Françoise Rousseau1, Pierre Damas2, Marc Janssens3, Saban Kalin3, Didier Ledoux2, Caroline Le Goff4, Romy Gadisseur4, Pierre Delanaye5, Etienne Cavalier4.   

Abstract

BACKGROUND: Interpretation of 25OH-D measurement during critical care (CC) may be problematic due to variations of binding protein concentrations (albumin, ALB, and vitamin D binding protein, VDBP). Determination of free 25OH-D concentration may thus be relevant in CC patients. The aim of this observational study was to evaluate effects of an acute hemodilution on vitamin D (VD) status.
METHODS: Blood samples were obtained before (T1) and after a crystalloid load (T2) administered at anesthesia induction for minor surgery. 25OH-D was measured with LC-MS/MS and with 3 immunoassays (IA): DiaSorin Liaison, IDS iSYS and bioMérieux Vidas. VDBP was measured with the R&D Elisa and ALB on Cobas. Free 25OH-D was calculated using published formula. Accuracy of each 25OH-D IA was calculated as the percentage of IA values within 20% of their respective LC-MS/MS values. Performances of the three AI were compared with LC-MC/MS using Bland-Altman analysis.
RESULTS: Twenty adults were included. Compared to T1 values, VDBP, ALB and LC-MS/MS values decreased in parallel by a mean of 23% at T2. IA values decreased less significantly (12, 14 and 15% for Liaison, iSYS and Vidas, respectively). IA-based calculated free 25OH-D significantly increased after dilution, while LC-MS/MS-based free values remained stable. At T1 and T2, bias were demonstrable for all IA. After hemodilution, bias would lead to overestimation for the three IA. Accuracy of IA decreased after dilution.
CONCLUSIONS: Due to matrix effects, compared to LC-MS/MS, IA results were impacted by hemodilution. In CC patients, LC-MS/MS seems to be the best option to measure 25OH-D. Specific LC-MS/MS method should be developed to measure free 25OH-D.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Critical care; Free 25-hydroxyvitamin D; Hemodilution; Immunoassay; Vitamin D

Mesh:

Substances:

Year:  2014        PMID: 25020235     DOI: 10.1016/j.cca.2014.07.007

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  10 in total

Review 1.  Vitamin D assays and the definition of hypovitaminosis D: results from the First International Conference on Controversies in Vitamin D.

Authors:  Christopher T Sempos; Annemieke C Heijboer; Daniel D Bikle; Jens Bollerslev; Roger Bouillon; Patsy M Brannon; Hector F DeLuca; Glenville Jones; Craig F Munns; John P Bilezikian; Andrea Giustina; Neil Binkley
Journal:  Br J Clin Pharmacol       Date:  2018-07-17       Impact factor: 4.335

2.  Effect of Cholecalciferol Supplementation on Vitamin D Status and Cathelicidin Levels in Sepsis: A Randomized, Placebo-Controlled Trial.

Authors:  Sadeq A Quraishi; Gennaro De Pascale; Joseph S Needleman; Harumasa Nakazawa; Masao Kaneki; Ednan K Bajwa; Carlos A Camargo; Ishir Bhan
Journal:  Crit Care Med       Date:  2015-09       Impact factor: 7.598

Review 3.  Vitamin D during pregnancy: why observational studies suggest deficiency and interventional studies show no improvement in clinical outcomes? A narrative review.

Authors:  S N Karras; P Anagnostis; D Naughton; C Annweiler; A Petroczi; D G Goulis
Journal:  J Endocrinol Invest       Date:  2015-07-29       Impact factor: 4.256

4.  The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club.

Authors:  E Cavalier; P Bergmann; O Bruyère; P Delanaye; A Durnez; J-P Devogelaer; S L Ferrari; E Gielen; S Goemaere; J-M Kaufman; A Nzeusseu Toukap; J-Y Reginster; A-F Rousseau; S Rozenberg; A J Scheen; J-J Body
Journal:  Osteoporos Int       Date:  2016-03-30       Impact factor: 4.507

5.  Comparison of Two ELISA Methods and Mass Spectrometry for Measurement of Vitamin D-Binding Protein: Implications for the Assessment of Bioavailable Vitamin D Concentrations Across Genotypes.

Authors:  Michelle R Denburg; Andrew N Hoofnagle; Samir Sayed; Jayanta Gupta; Ian H de Boer; Lawrence J Appel; Ramon Durazo-Arvizu; Krista Whitehead; Harold I Feldman; Mary B Leonard
Journal:  J Bone Miner Res       Date:  2016-06       Impact factor: 6.741

Review 6.  Recommendations on the measurement and the clinical use of vitamin D metabolites and vitamin D binding protein - A position paper from the IFCC Committee on bone metabolism.

Authors:  Konstantinos Makris; Harjit P Bhattoa; Etienne Cavalier; Karen Phinney; Christopher T Sempos; Candice Z Ulmer; Samuel D Vasikaran; Hubert Vesper; Annemieke C Heijboer
Journal:  Clin Chim Acta       Date:  2021-03-10       Impact factor: 6.314

7.  Vitamin D status in critically ill patients: back to basics!

Authors:  Anne-Françoise Rousseau; Etienne Cavalier
Journal:  Crit Care       Date:  2014-11-11       Impact factor: 9.097

8.  Evaluation of Bone Metabolism in Critically Ill Patients Using CTx and PINP.

Authors:  Alexandra Gavala; Konstantinos Makris; Anna Korompeli; Pavlos Myrianthefs
Journal:  Biomed Res Int       Date:  2016-11-29       Impact factor: 3.411

9.  Bad Prognosis in Critical Ill Patients with COVID-19 during Short-Term ICU Stay regarding Vitamin D Levels.

Authors:  Lourdes Herrera-Quintana; Yenifer Gamarra-Morales; Héctor Vázquez-Lorente; Jorge Molina-López; José Castaño-Pérez; Juan Francisco Machado-Casas; Ramón Coca-Zúñiga; José Miguel Pérez-Villares; Elena Planells
Journal:  Nutrients       Date:  2021-06-09       Impact factor: 5.717

Review 10.  Vitamin D status and its influence on outcomes following major burn injury and critical illness.

Authors:  Naiem Moiemen; Janet M Lord; Khaled Al-Tarrah; Martin Hewison
Journal:  Burns Trauma       Date:  2018-04-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.